 |
|
|
|---|---|---|
|
|
LVAD and ECMO
______________________________________________________________________________________ Publications The impact of hypogammagammaglobulinemia on infection outcome in patients undergoing ventricular assist device implantation. Ankersmit HJ, Hacker S, Hoetzenecker K, Moser B, Wolner E; The Journal of heart and lung transplantation 2006 Nov;25(11):1387-8. Abstract Apoptosis-specific activation markers in on- versus off-pump coronary artery bypass graft (CABG) patients. Szerafin T, Horvath A, Moser B, Hacker S, Hoetzenecker K, Steinlechner B, Brunner M, Roth G, Boltz-Nitulescu G, Peterffy A, Wolner E, Ankersmit HJ; Clinical laboratory 2006;52(5-6):255-61. Abstract Recovery from giant cell myocarditis with ECMO support and utilisation of polyclonal antithymocyte globulin: a case report. Ankersmit HJ, Ullrich R, Moser B, Hoetzenecker K, Hacker S, German P, Krenn C, Horvat R, Grimm M, Wolner E, Zuckermann A; The Thoracic and cardiovascular surgeon 2006 Jun;54(4):278-80. Abstract Extracorporeal membrane oxygenation is superior to right ventricular assist device for acute right ventricular failure after heart transplantation. Taghavi S, Zuckermann A, Ankersmit J, Wieselthaler G, Rajek A, Laufer G, Wolner E, Grimm M; The Annals of thoracic surgery 2004 Nov;78(5):1644-9. Abstract A retrospective analysis of extracorporel membrane oxygenation versus right ventricular assist device in acute great failure after heart transplantation. Taghavi S, Ankersmit J, Zuckermann A, Roth GA, Wieselthaler G, Rajek A, Wolner E, Grimm M; Transplantation proceedings 2003 Nov;35(7):2805-7. Immunobiologic consequences of assist devices. Itescu S, Schuster M, Burke E, Ankersmit J, Kocher A, Deng M, John R, Lietz K; Cardiology clinics 2003 Feb;21(1):119-33. Rapamycin as rescue therapy in a patient supported by biventricular assist device to heart transplantation with consecutive ongoing rejection. Ankersmit HJ, Roth G, Zuckermann A, Moser B, Obermaier R, Taghavi S, Brunner M, Wieselthaler G, Lanzenberger M, Ullrich R, Laufer G, Grimm M, Wolner E; American journal of transplantation 2003 Feb;3(2):231-4. Transitory immunologic response after implantation of the DeBakey VAD continuous-axial-flow pump. Ankersmit HJ, Wieselthaler G, Moser B, Gerlitz S, Roth G, Boltz-Nitulescu G, Wolner E; The Journal of thoracic and cardiovascular surgery 2002 Mar;123(3):557-61. B-cell activation and allosensitization after left ventricular assist device implantation is due to T-cell activation and CD40 ligand expression. Schuster M, Kocher A, John R, Hoffman M, Ankersmit J, Lietz K, Edwards N, Oz M, Itescu S; Human immunology 2002 Mar;63(3):211-20. Extracorporeal membrane oxygenation for graft failure after heart transplantation: recent Vienna experience. Taghavi S, Ankersmit HJ, Wieselthaler G, Gorlitzer M, Rajek A, Wolner E, Grimm M; The Journal of thoracic and cardiovascular surgery 2001 Oct;122(4):819-20. Induction of CD40 ligand expression in human T cells by biomaterials derived from left ventricular assist device surface. Schuster M, Kocher A, Lietz K, Ankersmit J, John R, Edwards N, Oz M, Itescu S; Transplantation proceedings 2001 Feb-Mar;33(1-2):1960-1. Induction of T-cell apoptosis by polyurethane biomaterials used in left ventricular assist devices is dependent on calcineurin activation. Schuster M, Ankersmit J, Kocher A, Lietz K, Schuster N, Hofmann M, John R, Edwards N, Oz M, Itescu S; Transplantation proceedings 2001 Feb-Mar;33(1-2):1958-9. Immunobiology of left ventricular assist devices. Itescu S, Ankersmit JH, Kocher AA, Schuster MD; Progress in cardiovascular diseases 2000 Jul-Aug;43(1):67-80. Intravenous immunoglobulin reduces anti-HLA alloreactivity and shortens waiting time to cardiac transplantation in highly sensitized left ventricular assist device recipients. John R, Lietz K, Burke E, Ankersmit J, Mancini D, Suciu-Foca N, Edwards N, Rose E, Oz M, Itescu S; Circulation 1999 Nov 9;100(19 Suppl):II229-35. Quantitative changes in T-cell populations after left ventricular assist device implantation: relationship to T-cell apoptosis and soluble CD95. Ankersmit HJ, Edwards NM, Schuster M, John R, Kocher A, Rose EA, Oz M, Itescu S; Circulation 1999 Nov 9;100(19 Suppl):II211-5. Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist device. Ankersmit HJ, Tugulea S, Spanier T, Weinberg AD, Artrip JH, Burke EM, Flannery M, Mancini D, Rose EA, Edwards NM, Oz MC, Itescu S; Lancet 1999 Aug 14;354(9178):550-5.
|
